GLP-1 use significantly lowered risk for atrial fibrillation-related events for patients with diabetes, AF and obesity, with ...

Between 1990 and 2017 the global deaths attributed to high body mass index more than doubled from 2.2 million to 4.7 million ...

Gut microbes in early life play a key role in shaping insulin production and diabetes risk, with Candida dubliniensis showing ...

Lilly trumpeted positive topline results from ACHIEVE-1 (NCT05971940) showing orforglipron to have met the trial’s primary ...

The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at certain dosages.

According to the American Diabetes Association (ADA), these cholesterol amounts ... academic research institutions, and medical journals and associations. We only use quality, credible sources ...

Fraternal Order of Eagles Diabetes Research Center (E.D.A.), University of Iowa Carver College of Medicine, Iowa City. For Sources of Funding and Disclosures, see page 1515. Corresponding to: E. Dale ...

The Idaho State Journal invites you to take part in the community conversation. But those who don't play nice may be uninvited.

DIABETES insipidus ordinarily is due to lack of the neurohypophyseal hormone, vasopressin, which enables the kidneys to form concentrated urine. Treatment consists of administering material ...

High blood pressure (hypertension) can lead to many complications of diabetes, including diabetic eye disease and kidney disease, or make them worse. Most people with diabetes will eventually have ...